دورية أكاديمية
أعرض في EDS

Incidence of Venous Thromboembolism in Adults Receiving Extracorporeal Membrane Oxygenation: A Systematic Review.

التفاصيل البيبلوغرافية
العنوان: Incidence of Venous Thromboembolism in Adults Receiving Extracorporeal Membrane Oxygenation: A Systematic Review.
المؤلفون: Iannattone PA; From the Department of Medicine, Jewish General Hospital, McGill University, Montréal, Quebec., Yang SS; Department of Anesthesia, Division of Critical Care, McGill University, Jewish General Hospital, Montréal, Quebec., Koolian M; Department of Medicine, Division of Internal Medicine, Center for Clinical Epidemiology and Community Studies, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec., Wong EG; Department of Surgery, Division of Critical Care, Jewish General Hospital, McGill University, Montréal, Quebec, Canada., Lipes J; Department of Anesthesia, Division of Critical Care, McGill University, Jewish General Hospital, Montréal, Quebec.
المصدر: ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2022 Dec 01; Vol. 68 (12), pp. 1523-1528. Date of Electronic Publication: 2022 Mar 19.
نوع المنشور: Systematic Review; Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9204109 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-943X (Electronic) Linking ISSN: 10582916 NLM ISO Abbreviation: ASAIO J Subsets: MEDLINE
أسماء مطبوعة: Publication: Hagerstown, MD : Lippincott Williams & Wilkins
Original Publication: Philadelphia, PA : Published for the Society by J.B. Lippincott Co., c1992-
مواضيع طبية MeSH: Extracorporeal Membrane Oxygenation*/adverse effects , Venous Thromboembolism*/etiology , Venous Thromboembolism*/complications , Pulmonary Embolism*/etiology, Adult ; Humans ; Incidence
مستخلص: Extracorporeal membrane oxygenation (ECMO) has become an increasingly used tool for cardiorespiratory support. Thrombosis is a well-recognized complication of ECMO, yet the burden of disease remains unclear. We undertook a systematic review to investigate the incidence of venous thromboembolism (VTE) during ECMO or soon after decannulation, in patients screened for VTE. We retrieved all studies that evaluated VTE incidence in ECMO patients in EMBASE, MEDLINE, Web of Science, and Cochrane Library from inception to April 2, 2021. Studies reporting incidence of VTE diagnosed on systematic screening tests during ECMO or within 7 days of decannulation in adult patients were included. A total of 18 studies were included in the systematic review. These studies screened a total of 1095 ECMO patients. Most studies screened for cannula-associated deep vein thrombosis (CaDVT) after decannulation. The overall incidence of DVT was 52.8% (95% CI, 49.8-55.8%). Incidence of DVT was 53.5% (95% CI, 50.0-57.0%) for venovenous ECMO vs. 34.0% (95% CI, 26.5-42.2%) for venoarterial ECMO. No studies screened for pulmonary embolism. Our systematic review found a very high incidence of DVT among patients treated with ECMO. Routine screening for DVT after decannulation for all ECMO patients may be warranted.
Competing Interests: Disclosure: There are no conflicts of interest.
(Copyright © ASAIO 2022.)
References: Lafç G, Budak AB, Yener AÜ, Cicek OF: Use of extracorporeal membrane oxygenation in adults. Heart Lung Circ. 23: 10–23, 2014.
Gerke AK, Tang F, Cavanaugh JE, Doerschug KC, Polgreen PM: Increased trend in extracorporeal membrane oxygenation use by adults in the United States since 2007. BMC Res Notes. 8: 686, 2015.
Sy E, Sklar MC, Lequier L, Fan E, Kanji HD: Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. J Crit Care. 39: 87–96, 2017.
Millar JE, Fanning JP, McDonald CI, McAuley DF, Fraser JF: The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care. 20: 387, 2016.
Zhang P, Bian Y, Xu F, et al.: The incidence and characteristics of venous thromboembolism in neurocritical care patients: a prospective observational study. Clin Appl Thromb Hemost. 26: 1076029620907954, 2020.
Gupta R, Ammari Z, Dasa O, et al.: Long-term mortality after massive, submassive, and low-risk pulmonary embolism. Vasc Med. 25: 141–149, 2020.
Bach AG, Taute BM, Baasai N, et al.: 30-day mortality in acute pulmonary embolism: prognostic value of clinical scores and anamnestic features. PLoS One. 11: e0148728, 2016.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6: e1000097, 2009.
Rayyan Systems Inc. Available at: https://rayyan.qcri.org/ . Accessed April 2 nd , 2021.
Joanna Briggs Institute. Checklist for systematic reviews and research syntheses(2017). Available at: https://jbi.global/critical-appraisal-tools . Accessed July 2, 2021.
Abulmagd E, Charlesworth M, Duggal M, MacDonald J, Feddy L. Deep vein thrombosis following VV-ECMO for acute respiratory failure: A retrospective case note audit in South Manchester. [abstract] Anaesthesia. 72 (Supplement 4):40, 2017.
Bidar F, Lancelot A, Lebreton G, et al.: Venous or arterial thromboses after venoarterial extracorporeal membrane oxygenation support: frequency and risk factors. J Heart Lung Transplant. 40: 307–315, 2021.
Boddi M, Cianchi G, Cappellini E, et al. Cannula-related deep vein thrombosis during extracorporeal membrane oxygenation (ECMO) treatment do not affect mortality and length of stay in intensive care unit. [abstract] Critical Care Conference: 37th International Symposium on Intensive Care and Emergency Medicine Belgium 2017;21(Supplement 1).
Cavaleiro P, Crescenzi O, Rawal B, et al. Thrombosis after ECMO: We should start looking into the inferior vena cava. [abstract] Perfusion. 35(1 SUPPL):220–221, 2020.
Cooper E, Burns J, Retter A, et al.: Prevalence of venous thrombosis following venovenous extracorporeal membrane oxygenation in patients with severe respiratory failure. Crit Care Med. 43: e581–e584, 2015.
Doyle AJ, Pandey M, Shah R, Barrett N, Retter A. Monitoring and outcomes of patients with Anti-Xa versus APTTr monitoring of unfractionated heparin infusions during extracorporeal membrane oxygenation. [abstract] Perfusion. 35 (1 SUPPL):224, 2020.
Fisser C, Reichenbächer C, Müller T, et al.: Incidence and risk factors for cannula-related venous thrombosis after venovenous extracorporeal membrane oxygenation in adult patients with acute respiratory failure. Crit Care Med. 47: e332–e339, 2019.
Menaker J, Tabatabai A, Rector R, et al.: Incidence of cannula-associated deep vein thrombosis after veno-venous extracorporeal membrane oxygenation. ASAIO J. 63: 588–591, 2017.
Panigada M, Cucino A, Spinelli E, et al.: A randomized controlled trial of antithrombin supplementation during extracorporeal membrane oxygenation. Crit Care Med. 48: 1636–1644, 2020.
Panigada M, Iapichino GE, Brioni M, et al.: Thromboelastography-based anticoagulation management during extracorporeal membrane oxygenation: a safety and feasibility pilot study. Ann Intensive Care. 8: 7, 2018.
Parzy G, Daviet F, Persico N, et al.: Prevalence and risk factors for thrombotic complications following venovenous extracorporeal membrane oxygenation: a CT scan study. Crit Care Med. 48: 192–199, 2020.
Shafii AE, Brown CR, Murthy SC, Mason DP: High incidence of upper-extremity deep vein thrombosis with dual-lumen venovenous extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 144: 988–989, 2012.
Smith N, Trigonis R, Rahman O, et al.: Bivalirudin as therapeutic anticoagulation in COVID-19 patients on ECMO. [abstract] ASAIO J. 66 (SUPPL 3):15, 2020.
Stokes JW, Gannon WD, Sherrill WH, et al.: Bleeding, thromboembolism, and clinical outcomes in venovenous extracorporeal membrane oxygenation. Crit Care Explor. 2: e0267, 2020.
Shtraichman O, Courtwright A, Diamond JM, et al.: Deep vein thrombosis in extracorporeal membrane oxygenation bridged lung transplant recipients. [abstract] J Heart Lung Transplant. S. 39:S319, 2020.
Todd E, Roy SB, Kang P, et al.: Low antithrombin levels pre-ECMO may predict venous thromboembolism after lung transplantation. [abstract] J Heart Lung Transplant. 36:S255–S255, 2017.
Van Minnen O, Van Den Bergh WM, Droogh J, et al.: Incidence and risk factors of deep vein thrombosis after extracorporeal membrane oxygenation. tensive Care Medicine Experimental Conference: 33rd European Society of Intensive Care Medicine Annual Congress, [abstract] ESICM. 8(SUPPL 2), 2020.
Vazquez ZGS, Sodha NR, Devers C, Ventetuolo CE, Abbasi A: Prevalence of deep vein thrombosis in patients supported with extracorporeal membrane oxygenation. ASAIO J. 67: e169–e171, 2021.
Boddi M, Peris A: Deep vein thrombosis in intensive care. Adv Exp Med Biol. 906: 167–181, 2017.
Geerts W: Central venous catheter-related thrombosis. Hematology Am Soc Hematol Educ Program. 2014: 306–311, 2014.
Thrombosis Canada. Central venous catheter-related deep vein thrombosis. 2021. Available at: https://thrombosiscanada.ca/wp-uploads/uploads/2021/09/1.-Central-Venous-Catheter_14Sept2021.pdf . Accessed September 14 th , 2021.
Garcia DA, Baglin TP, Weitz JI, Samama MM: Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9 th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 141(2 Suppl): e24S–e43S, 2012.
Scherer RW, Saldanha IJ: How should systematic reviewers handle conference abstracts? A view from the trenches. Syst Rev. 8: 264, 2019.
تواريخ الأحداث: Date Created: 20221205 Date Completed: 20221207 Latest Revision: 20230203
رمز التحديث: 20240628
DOI: 10.1097/MAT.0000000000001694
PMID: 36469448
قاعدة البيانات: MEDLINE
الوصف
تدمد:1538-943X
DOI:10.1097/MAT.0000000000001694